Alpha-toxin-elicited CX <sub>3</sub> CL1 release in <i>Staphylococcus aureus</i> pneumonia impairs bactericidal function of human monocytes
<i>Staphylococcus aureus</i> is an important human pathogen causing severe invasive infections. Pathogenesis is attributed to a wide array of virulence factors, including several potent exotoxins such as the pore-forming α-toxin. In this study, we found that patients with <i>S. aureus</i> respiratory tract infections had elevated CX<sub>3</sub>CL1 levels in airway fluid and plasma. Using human-organotypic lung models, we observed that stimulation of lung epithelium with α-toxin induces an intensified CX<sub>3</sub>CL1 expression apically in the epithelium as well as the release of CX<sub>3</sub>CL1. Blocking α-toxin or ADAM10 activity in organotypic lung using an α-toxin-blocking antibody or a specific ADAM10 inhibitor confirmed their role in modulating CX<sub>3</sub>CL1 cleavage and release. Analyses of CD14<sup>+</sup> human monocytes in combination with a CX<sub>3</sub>CR1 inhibitor revealed that α-toxin-mediated CX<sub>3</sub>CL1 release induces CX<sub>3</sub>CL1-dependent chemotaxis. In line with these data, lung tissue from patients with <i>S. aureus</i> respiratory tract infection showed elevated CX<sub>3</sub>CL1 and CD14 staining as compared with tissue from patients with non-infectious lung diseases. Functional studies of monocytes showed that CX<sub>3</sub>CL1 released by lung models resulted in upregulated CD83 and downregulated CD86, as well as impaired killing of phagocytosed <i>S. aureus</i>. Furthermore, stimulation of monocytes with soluble CX<sub>3</sub>CL1 hampered their reactive-oxygen and nitric-oxide production. Taken together our data show that <i>S. aureus</i> triggers the release of lung epithelial CX<sub>3</sub>CL1, and we identify an immunomodulatory effect of α-toxin involving its cytotoxic and ADAM10-interacting properties, inducing CX<sub>3</sub>CL1 release leading to impaired monocyte effector function.IMPORTANCEExotoxins are essential virulence factors for the pathobiont <i>S. aureus</i> and contribute toward severe invasive infections such as pneumonia. <i>S. aureus</i> α-toxin is a pore-forming exotoxin that causes host cell lysis and severe lung pathology. We found that α-toxin drives the release of membrane-bound chemokine CX<sub>3</sub>CL1 by involving ADAM10-mediated proteolytic activity. Furthermore, the release of CX<sub>3</sub>CL1 modulated immune responses locally, as demonstrated by enhanced monocyte migration and reduced capacity of monocytes to kill ingested bacteria. CX<sub>3</sub>CL1-induced reduction in bacterial killing coincided with impaired production of reactive oxygen and nitric oxide species. This reveals a novel mechanism in the pathogenesis of <i>S. aureus</i> lung infections involving α-toxin-induced release of CX<sub>3</sub>CL1, leading to impaired bacterial killing by monocytes.
Authors
- Danen Mootoosamy Cunoosamy (ORCID: https://orcid.org/0000-0002-9044-7281)
- Kristoffer Strålin (ORCID: https://orcid.org/0000-0002-8801-3169)
- Sara Cajander (ORCID: https://orcid.org/0000-0003-3921-4244)
- Magda Lourda (ORCID: https://orcid.org/0000-0003-3155-1123)
- Markus Huemer (ORCID: https://orcid.org/0000-0002-4308-1619)
- Tiziano A. Schweizer (ORCID: https://orcid.org/0000-0002-4135-6527)
- Annelies S. Zinkernagel (ORCID: https://orcid.org/0000-0003-4700-1118)
- Puran Chen (ORCID: https://orcid.org/0000-0002-2890-0022)
- Taylor S. Cohen (ORCID: https://orcid.org/0000-0001-9368-0903)
- Alejandro Gómez-Mejía (ORCID: https://orcid.org/0000-0002-7313-7169)
- Samuel B. Berry (ORCID: https://orcid.org/0000-0002-2985-1904)
- Volkan Özenci (ORCID: https://orcid.org/0000-0002-8069-4027)
- Virginia Takahashi
- Srikanth Mairpady Shambat (ORCID: https://orcid.org/0000-0002-0527-3978)
- Rocky Barilla (ORCID: https://orcid.org/0000-0002-8062-7246)
- Anna Norrby‐Teglund (ORCID: https://orcid.org/0000-0001-9372-1795)
- Amanda Welin (ORCID: https://orcid.org/0000-0001-8460-5952)
- Johanna Snäll (ORCID: https://orcid.org/0000-0002-3918-4295)
- Mattias Svensson (ORCID: https://orcid.org/0000-0003-1695-7934)
- Reto Schüpbach
- Ewerton Marques Maggio
Institutions
- Brigham and Women's Hospital (US)
- Karolinska University Hospital (SE)
- University of Zurich (CH)
- Örebro University (SE)
- Karolinska Institutet (SE)
- Women's & Children's Health Research Institute (AU)
- University Hospital of Zurich (CH)
- Integrated Cardio Metabolic Centre (SE)
- AstraZeneca (France) (FR)
- AstraZeneca (Singapore) (SG)
- AstraZeneca (Switzerland) (CH)
- AstraZeneca (Finland) (FI)
Publication Details
- Journal
- mBio
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1128/mbio.02689-25
- Citations
- 2
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 2.37